Intellia Therapeutics Inc buy Oppenheimer Holdings Inc.
Start price
13.01.25
/
50%
€9.72
Target price
13.01.26
€39.21
Performance (%)
4.78%
End price
14.01.26
€10.18
Summary
This prediction ended on 14.01.26 with a price of €10.18. The BUY prediction by Oppenheimer_Holdings finished with a performance of 4.78%. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 10.243% | 10.243% | 99.623% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $60.00 to $40.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Oppenheimer_Holdings for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€16.19
11.11.24
11.11.24
€56.29
11.11.25
11.11.25
-46.53%
12.11.25
12.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.25
13.11.23
13.11.23
€65.39
13.11.24
13.11.24
-30.31%
14.11.24
14.11.24